1
U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
- --------------------------------------------------------------------------------
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): July 17, 2001
AMEDISYS, INC.
--------------
(Exact Name of Registrant as Specified in Charter)
Delaware
--------
(State or Other Jurisdiction of
Incorporation or Organization)
0-24260 11-3131700
------- ----------
(Commission File Number) (I.R.S. Employer Identification No.)
11100 Mead Road, Suite 300, Baton Rouge, LA 70816
-------------------------------------------------
(Address of principal executive offices
including zip code)
(225) 292-2031
--------------
(Registrant's telephone number, including area code)
2
ITEM 5. OTHER EVENTS
On July 17, 2001, Amedisys, Inc., "the Company",
issued a press release attached hereto as Exhibit 99.1 to
quantify a net revenue overstatement previously announced.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
(a) Financial Statements of Business Acquired.
Not applicable.
(b) Pro Forma Financial Information.
Not applicable.
(c) Exhibit
No. Page
------- ----
99.1 (i) Press Release dated July 17, 2001 quantifying
a net revenue overstatement previously
announced.......................................A-1
(i) Filed herewith.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
AMEDISYS, INC.
By: /s/ John M. Joffrion
---------------------------------------
John M. Joffrion
Senior Vice President of Finance
Principal Accounting and Financial Officer
DATE: July 17, 2001
3
INDEX TO EXHIBITS
EXHIBIT
NO. DESCRIPTION PAGE
- ------- ----------- ----
99.1(i) Press Release dated July 17, 2001 quantifying a net
revenue overstatement..................................A-1
(i) Filed herewith.